Moscow/Sputnik: US pharmaceutical company Moderna said it planned to produce at least 600 million doses of its vaccine against COVID-19 in 2021, not 500 million as previously announced.
Boston: A Boston doctor, who has shellfish allergy, developed a severe allergic reaction after taking a shot of the Moderna COVID-19 Vaccine, media reports said.
Washington: The United States has approved Moderna's COVID-19 vaccine, paving the way for the release of millions of doses.
London: Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, on Monday said ...
Giving humanity yet another hope that a solution will be reached soon, US Biotech major Moderna said its COVID-19 vaccine induced a robust immune response and prevented the coronavi ...
Boston: A Coronavirus vaccine developed by biotechnology company Moderna showed positive response in phase 1 study.
New York/IBNS: Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for pa ...
- Moderna delays shipment of about 600,000 doses of COVID-19 vaccine to Canada
- Moderna says plans to produce at least 600 million doses of COVID-19 vaccine in 2021
- US: Doctor develops severe allergic reaction after receiving Moderna COVID-19 vaccine
- US approves Moderna COVID-19 vaccine
- Moderna says its COVID-19 vaccine shows nearly 95 pct efficiency